
Chipiron is developing scalable MRI technologies with the goal of making MRI 100x more accessible to enable widespread early diagnosis and image-guided therapies for deadly diseases. Their innovative approach leverages ultra-low magnetic fields (<10 mT) to create a light, inexpensive, open full-body MRI machine without compromising image quality. Key technological advancements include a patented low-Tc SQUID volume gradiometer for improved SNR, an AI noise cancellation system, an MRI-compatible cryostat for an ultra-light cooling system, and unconventional low-field AI reconstruction techniques to reduce acquisition times. Chipiron has secured significant funding, including a $17M Series A, and has received grants from EIC Accelerator and France 2030. They were recognized with the 'Innovation of the Year' award at VivaTech 2025 by TechCrunch. Their roadmap includes prototyping in August 2024, achieving clinical-grade image quality by November 2025, and targeting FDA submission by September 2026. The company aims to make MRI as common as blood sampling.

Chipiron is developing scalable MRI technologies with the goal of making MRI 100x more accessible to enable widespread early diagnosis and image-guided therapies for deadly diseases. Their innovative approach leverages ultra-low magnetic fields (<10 mT) to create a light, inexpensive, open full-body MRI machine without compromising image quality. Key technological advancements include a patented low-Tc SQUID volume gradiometer for improved SNR, an AI noise cancellation system, an MRI-compatible cryostat for an ultra-light cooling system, and unconventional low-field AI reconstruction techniques to reduce acquisition times. Chipiron has secured significant funding, including a $17M Series A, and has received grants from EIC Accelerator and France 2030. They were recognized with the 'Innovation of the Year' award at VivaTech 2025 by TechCrunch. Their roadmap includes prototyping in August 2024, achieving clinical-grade image quality by November 2025, and targeting FDA submission by September 2026. The company aims to make MRI as common as blood sampling.
Product: Ultra-low-field (<10 mT) full-body portable MRI using SQUID detectors and lightweight cryostat
Mission: Make MRI ~100x more accessible for early diagnosis and image-guided therapies
Funding: Raised a $17M Series A (Apr 30, 2025) plus multiple public grants (EIC Accelerator, France 2030)
HQ & founding: Paris, France; founded 2020
| Company |
|---|
Increase accessibility of MRI for early disease diagnosis and image-guided therapies by reducing cost, weight, and facility requirements.
2020
Medical Equipment Manufacturing
€2.5M grant + €15M equity
€3.6M
Non-dilutive
$17M
“Multiple public grants and a $17M Series A including participation from public innovation programs and venture investors (e.g., France 2030, EIC Accelerator, Blast. Club)”
We’re looking for a highly motivated Ops Associate Intern to join our team and support both the Chief of Staff and our HR/Talent Manager on cross-functional projects. This internship is ideal for a final-year student from a business or engineering school looking to gain hands-on experience in a fast-paced startup environment.
Duration: 6 months
From: Mid-September 2025 (Flexible)
Skills & Experience
Key Responsibilities
Who We Are Chipiron is revolutionizing the medical imaging industry by developing light and easily deployable MRI machines powered by an ultra-sensitive quantum detection system. Our mission is to make MRI accessible to everyone, everywhere. We're a team of engineers based in the heart of Paris, and we have only one obsession: building things people want.
Our Culture